IRIS
MORI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.670
EU - Europa 4.133
AS - Asia 519
SA - Sud America 10
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 5
Totale 10.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.656
GB - Regno Unito 1.105
IE - Irlanda 1.008
IT - Italia 615
SE - Svezia 332
CN - Cina 321
UA - Ucraina 309
FR - Francia 296
DE - Germania 172
FI - Finlandia 88
RU - Federazione Russa 62
VN - Vietnam 62
SG - Singapore 49
ES - Italia 39
CZ - Repubblica Ceca 35
TR - Turchia 29
BE - Belgio 17
CA - Canada 13
IN - India 13
PL - Polonia 13
IR - Iran 9
JP - Giappone 9
NL - Olanda 9
AU - Australia 8
BG - Bulgaria 8
EU - Europa 7
CH - Svizzera 6
HK - Hong Kong 5
BR - Brasile 4
ID - Indonesia 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
SA - Arabia Saudita 3
BD - Bangladesh 2
CL - Cile 2
CY - Cipro 2
DK - Danimarca 2
EC - Ecuador 2
GR - Grecia 2
LV - Lettonia 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
JO - Giordania 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SS - ???statistics.table.value.countryCode.SS??? 1
TH - Thailandia 1
TJ - Tagikistan 1
ZA - Sudafrica 1
Totale 10.354
Salva come PNG Salva come JPEG
Città #
Southend 1.012
Dublin 1.003
Fairfield 940
Ashburn 567
Woodbridge 476
Seattle 413
Chandler 353
Wilmington 348
Houston 336
Cambridge 328
Siena 227
Jacksonville 219
Ann Arbor 207
Menlo Park 201
Princeton 200
San Mateo 97
Beijing 90
New York 73
San Diego 67
Nanjing 65
Dong Ket 62
Moscow 61
Redwood City 60
Boardman 58
Helsinki 55
Fremont 39
Rome 36
Milan 35
Florence 29
London 27
Brno 26
Shanghai 26
Singapore 25
Izmir 24
Nanchang 22
Salamanca 21
Norwalk 18
Shenyang 18
Brussels 17
Dearborn 15
Phoenix 15
Jinan 14
Málaga 13
Munich 12
San Francisco 12
Düsseldorf 11
Venezia 10
Changsha 9
Hebei 9
Kunming 8
Padova 8
Sofia 8
Toronto 8
Guangzhou 7
Jiaxing 7
Kilburn 7
Hounslow 6
Ningbo 6
Olomouc 6
Pisa 6
Taizhou 6
Tianjin 6
Bari 5
Bologna 5
Bonndorf 5
Lappeenranta 5
Los Angeles 5
Perugia 5
Arezzo 4
Bagno A Ripoli 4
Genoa 4
Jakarta 4
Miami 4
Palermo 4
Parma 4
Sydney 4
Tokyo 4
Turin 4
Zanjan 4
Zhengzhou 4
Berlin 3
Boston 3
Brescia 3
Cairo 3
Dubai 3
Esslingen am Neckar 3
Falkenstein 3
Fort Worth 3
Fuzhou 3
Genova 3
Haikou 3
Hangzhou 3
Hong Kong 3
Islington 3
Melbourne 3
Naples 3
Novara 3
Nuremberg 3
Porto 3
Prescot 3
Totale 8.228
Salva come PNG Salva come JPEG
Nome #
Structure, function, involvement in diseases and targeting of 14-3-3 proteins: An Update 208
Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02 204
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains 192
Potent and selective carboxylic acid inhibitors of tumor-associated carbonic anhydrases IX and XII 189
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors 186
Molecular insights to the bioactive form of BV02, a reference inhibitor of 14-3-3σ protein-protein interactions 184
In Memory of Maurizio Botta: His Contribution to the Development of Computer-Aided Drug Design 178
Differentially activated Src kinase in chemo-naive human primary osteosarcoma cells and effects of a Src kinase inhibitor 172
Discovery of in vitro antitubercular agents through in silico ligand-based approaches 167
Tautomers of a Fluorescent G Surrogate and Their Distinct Photophysics Provide Additional Information Channels 162
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3s case 161
Discovery of 14-3-3 Protein-Protein Interaction Inhibitors that Sensitize Multidrug-Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693 155
Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors 154
Structure Prediction and Validation of the ERK8 Kinase Domain 143
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors 142
Multitarget hedgehog pathway inhibitors and uses thereof 142
Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1 140
Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein 138
Small molecules modulation of 14-3-3 protein–protein interactions 137
Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B 132
Predicting the binding mode of known NCp7 inhibitors to facilitate the design of novel modulators 130
Mycobacterial carbonic anhydrase inhibition with phenolic acids and esters: kinetic and computational investigations 129
Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor. 128
Molecular Dynamics and DFT Study on HIV-1 Nucleocapsid Protein-7 in Complex with Viral Genome. 124
Targeting Protein-Protein and Protein-Nucleic Acid Interactions for Anti-HIV Therapy 124
Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated caxii 124
Free energy profile and kinetics studies of paclitaxel internalization from the outer to the inner wall of microtubules 123
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 123
Nucleocapsid protein: A desirable target for future therapies against HIV-1 122
A Class of Potent Inhibitors of the HIV-1 Nucleocapsid Protein Based on Aminopyrrolic Scaffolds 122
Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein 121
Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid protein. 117
Predicting the Binding Mode of Known NCp7 Inhibitors To Facilitate the Design of Novel Modulators. 115
Hit Recycling: Discovery of a Potent Carbonic Anhydrase Inhibitor by in Silico Target Fishing 115
Discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (PtpB) inhibitors from natural products 114
null 114
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein 114
Identification of Phosphate-Containing Compounds as New Inhibitors of 14-3-3/c-Abl Protein-Protein Interaction 111
Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity 110
Natural products inspired modulators of cancer stem cells-specific signaling pathways notch and hedgehog 105
A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro 105
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity 103
null 100
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines 99
Probing the Pore Drug Binding Site ofMicrotubules with Fluorescent Taxanes:Evidence of Two Binding Poses 98
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 95
1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma 93
Targeting GLI factors to inhibit the Hedgehog pathway 93
Histone demethylating agents as potential S-adenosyl-l-methionine-competitors 91
Nigritanine as a new potential antimicrobial alkaloid for the treatment of staphylococcus aureus-induced infections 91
Statins interfere with the attachment of S. cerevisiae mtDNA to the inner mitochondrial membrane 90
Chalcones and Chalcone-mimetic Derivatives as Notch Inhibitors in a Model of T-cell Acute Lymphoblastic Leukemia 85
Experimental and Computational Druggability Exploration of the 14-3-3ζ/SOS1pS1161PPI Interface 85
A smo/gli multitarget hedgehog pathway inhibitor impairs tumor growth 83
A Molecular Tool Targeting the Base-Flipping Activity of Human UHRF1 83
Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90 chaperone 83
Current trends in Hedgehog signaling pathway inhibition by small molecules 81
Oregonin from Alnus incana bark affects DNA methyltransferases expression and mitochondrial DNA copies in mouse embryonic fibroblasts 78
Synthetic thiosemicarbazones as a new class of Mycobacterium tuberculosis protein tyrosine phosphatase A inhibitors 76
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge 75
P300/CBP-associated factor regulates transcription and function of isocitrate dehydrogenase 2 during muscle differentiation 74
A deadly spillover: SARS-CoV-2 outbreak 74
Synthesis of distal and proximal fleximer base analogues and evaluation in the nucleocapsid protein of HIV-1 73
A chalcone derivative binds a putative allosteric site of YopH: Inhibition of a virulence factor of Yersinia 73
Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold 72
Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold 70
Excited-State Dynamics of Thienoguanosine, an Isomorphic Highly Fluorescent Analogue of Guanosine 69
One hundred faces of cyclopamine 68
Targeting the nucleocapsid protein of HIV-1 (NCp7) with nucleobase flexibility 66
A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome 63
Yeast as a tool to select inhibitors of the cullin deneddylating enzyme Csn5 61
Hedgehog signaling pathway inhibitors: an updated patent review (2015–present) 59
Natural products as an important source in drug discovery 59
Synthesis of flexible purine analog inhibitors of NCp7 58
Imidazo[1,2-a]pyridine derivatives as aldehyde dehydrogenase inhibitors: novel chemotypes to target glioblastoma stem cells 58
INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARN T 58
Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia 57
14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban 57
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors 57
Dual SMO/BRAF inhibition by flavonolignans from Silybum marianum† 55
Molecular Dynamics Simulations and Structural Analysis of Giardia Duodenalis 14-3-3 Protein-Protein Interactions 53
Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype 53
Alvaxanthone, a thymidylate synthase inhibitor with nematocidal and tumoricidal activities 53
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 53
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma 53
Conformational insights into the C-terminal mutations of human rhodopsin in retinitis pigmentosa 52
Occurrence of Enantioselectivity in Nature: The Case of (S)-Norcoclaurine 51
Potency and Selectivity Optimization of Tryptophanol-Derived Oxazoloisoindolinones: Novel p53 Activators in Human Colorectal Cancer 50
In Memory of Maurizio Botta: His Vision of Medicinal Chemistry 50
Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein 49
What makes thienoguanosine an outstanding fluorescent DNA probe? 45
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells 44
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: synthesis and biological evaluation for chronic myeloid leukemia treatment 44
Repurposing drugs for the management of COVID-19 43
Active Components from Cassia abbreviata Prevent HIV-1 Entry by Distinct Mechanisms of Action 42
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 ddiabetes patients: Rescue by alpha-ketoglutarate and TET-TDG functional reactivation 40
Click reaction as a tool to combine pharmacophores: The case of Vismodegib 39
Compounds for use in the treatment of brain diseases 39
Ent-Beyerane Diterpenes as a Key Platform for the Development of ArnT-Mediated Colistin Resistance Inhibitors 39
Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia 37
Totale 9.668
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.799 155 61 87 197 89 102 252 259 226 180 73 118
2020/20212.667 74 138 113 120 631 339 152 397 126 263 86 228
2021/20221.469 78 183 148 30 51 89 75 53 119 154 176 313
2022/20231.669 144 172 249 237 95 351 33 119 142 37 44 46
2023/20241.725 48 32 130 139 39 395 518 60 13 38 51 262
2024/202548 48 0 0 0 0 0 0 0 0 0 0 0
Totale 10.762